Legal Representation
Attorney
Lawrence E. Abelman
USPTO Deadlines
Application History
11 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 11, 2003 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 6, 2003 | I | PAPER RECEIVED | Loading... | |
| Jan 2, 2003 | ABN1 | S | ABANDONMENT - EXPRESS MAILED | Loading... |
| Nov 19, 2002 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 30, 2002 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Sep 16, 2002 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 11, 2002 | CNEA | O | EXAMINERS AMENDMENT MAILED | Loading... |
| Aug 8, 2002 | I | PAPER RECEIVED | Loading... | |
| Aug 8, 2002 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 7, 2002 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Feb 1, 2002 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for medical, therapeutic and/or prophylactic use in the treatment and/or prevention of defects to the central nervous system and/or the peripheral nervous system; and diagnostic preparations for clinical or medical laboratory use
First Use Anywhere:
0
First Use in Commerce:
0
Class 040
Treatment of protein-like substances, namely, chemical treatment for medical use, research or diagnostic purposes; treatment of protein-like substances with characteristics that have a positive influence on the treatment and/or prevention of defects to the central nervous system and/or the peripheral nervous system, namely, chemical treatment for others
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Scientific research of protein-like substances with characteristics that have a positive influence of the treatment and/or prevention of defects to the central nervous system and/or the peripheral nervous system; and research, namely, scientific, chemical and medical research and testing of protein-like substrances with characteristics that have a positive influence on the treatment and/or prevention of defects to the central nervous system and/or the peripheral nervous system for diagnostic purposes
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
040
042